CS1 cell surface expression was observed to be significantly higher in CD14+ monocytes of very high-risk (39.32%; p < 0.05) and high-risk (38.08%; p < 0.01) ALL subjects, respectively, at diagnosis (1BD) as compared to healthy (14.71%) subjects (Figure 4C). Here, CD14 is linked to acute lymphoblastic leukemia.